Replies to post #142408 on Biotech Values

[NP1986]

Agreed - but it is an interesting and non-intuitive effect. Damaging the OS I can understand (via toxicity to patient), but accelerated tumor growth commonly occurring across the meta-class is just very counter intuitive to me.

Toxicity could also explain the effect on PFS, if it leads to early treatment discontinuation.

Treatment-related deaths would also be counted as an event for PFS, wouldn't they?